Paper · 429327

Fractionation of low molecular weight heparin species and their interaction with antithrombin.

Beeler D and 2 others. J Biol Chem, 1979. Cited by 198 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Fractionation of low molecular weight heparin species and their interaction with antithrombin. Papers, record 429327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/429327

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Fractionation of low molecular weight heparin species and their interaction with antithrombin.; PubMed
Journal: J Biol Chem; PubMed
Year: 1979; PubMed
Publication types: Journal Article, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/429327/; PubMed
The journal: https://conductscience.org/library/journal-index/2985121R; PubMed
Citations, by iCite: 198; iCite
Relative citation ratio, by iCite: 6.81; iCite
Revised in PubMed: 2021-02-10; PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Beeler D	D
2	Rosenberg R	R
3	Jordan R	R

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Antithrombins	Major topic
Heparin	Major topic
Humans
Kinetics
Molecular Weight
Protein Binding
Spectrometry, Fluorescence
Thrombin

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 198 citations.

PMID	Title	Journal	Year	In Papers	Source
34,653,316	Targeted SERPIN (TaSER): A dual-action antithrombotic agent that targets platelets for SERPIN delivery.	J Thromb Haemost	2022	https://conductscience.org/library/papers/34653316	PubMed
33,869,308	Therapeutic SERPINs: Improving on Nature.	Front Cardiovasc Med	2021	https://conductscience.org/library/papers/33869308	PubMed
31,366,623	Design and characterization of α1-antitrypsin variants for treatment of contact system-driven thromboinflammation.	Blood	2019	https://conductscience.org/library/papers/31366623	PubMed
28,126,521	HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.	Matrix Biol	2017	https://conductscience.org/library/papers/28126521	PubMed
25,065,530	Probing the coagulation pathway with aptamers identifies combinations that synergistically inhibit blood clot formation.	Chem Biol	2014	https://conductscience.org/library/papers/25065530	PubMed
23,421,467	Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells.	Cancer Sci	2013	https://conductscience.org/library/papers/23421467	PubMed
21,272,054	Understanding the time course of pharmacological effect: a PKPD approach.	Br J Clin Pharmacol	2011	https://conductscience.org/library/papers/21272054	PubMed
21,078,289	Applications of phasor plots to in vitro protein studies.	Anal Biochem	2011	https://conductscience.org/library/papers/21078289	PubMed
19,707,288	The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.	Vasc Health Risk Manag	2009	https://conductscience.org/library/papers/19707288	PubMed
18,348,167	Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan binding and weakens cell adhesion.	J Cell Biochem	2008	https://conductscience.org/library/papers/18348167	PubMed

1 to 10 of 31

See all 31 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
F2	2,147	PubTator's text mining	https://conductscience.org/library/genes/2147	NCBI Gene
SERPINC1	462	PubTator's text mining	https://conductscience.org/library/genes/462	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/429327

GET https://conductscience.org/api/papers/v1/429327/cited_by?page=2

API reference For AI assistants